Avanos Medical (AVNS) Share-based Compensation (2013 - 2026)

Avanos Medical has disclosed Share-based Compensation across 14 years of filings, most recently posting $3.7 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $3.7 million, down 2.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.5 million (down 10.71% YoY), and the FY2025 annual result was $12.6 million, down 8.7% from the prior year.
• Share-based Compensation came in at $3.7 million for Q1 2026 at Avanos Medical, up from $1.2 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.1 million in Q3 2022 to a low of $1.2 million in Q4 2025.
• The 5-year median for Share-based Compensation is $3.8 million (2022), against an average of $3.6 million.
• Peak annual rise in Share-based Compensation reached 34.62% in 2025, while the deepest fall reached 68.42% in 2025.
• Avanos Medical's Share-based Compensation stood at $4.0 million in 2022, then changed by 0.0% to $4.0 million in 2023, then dropped by 5.0% to $3.8 million in 2024, then tumbled by 68.42% to $1.2 million in 2025, then soared by 208.33% to $3.7 million in 2026.
• The last three Share-based Compensation figures came in at $3.7 million (Q1 2026), $1.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.